Article
Aphanin, a triterpenoid from Amoora rohituka inhibits K-Ras mutant activity and STAT3 in pancreatic carcinoma cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Sept 2016
Rabi Thangaiyan, Catapano Carlo V
Abstract excerpt
Mutations of the K-Ras gene occur in over 90 % of pancreatic carcinomas, and to date, no targeted therapies exist for this genetically defined subset of cancers. STAT3 plays a critical role in KRAS-driven pancreatic tumorigenesis, suggesting its potential as a therapeutic target in this cancer. Therefore, finding novel and potential drugs to inhibit oncogenic K-Ras is a major challenge in cancer therapy. In an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
